atenolol has been researched along with Recrudescence in 28 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 h after the onset of suspected acute myocardial infarction were randomised either to a control group or to a group receiving atenolol (5-10 mg iv immediately, followed by 100 mg/day orally for 7 days)." | 9.06 | Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. ( , 1986) |
| "One hundred thirty-one patients presenting with acute myocardial infarction (AMI) a mean of 3 hours after the onset of symptoms were treated with oral aspirin and intravenous thrombolytic therapy followed by heparin." | 7.68 | Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction. ( Commerford, PJ; Gordon, GD; Green, BK; Horak, AR; Millar, RN, 1992) |
| "To study the efficacy of medical treatment for preventing syncopal recurrences in patients affected by tilt-induced neurally mediated syncope, a randomized placebo-treatment prospective study was performed in 30 patients (10 men and 20 women, mean age 42 +/- 21 years) who had syncope reproduced in 2 consecutive head-up tilt-table tests without pharmacologic intervention (n = 20) or during isoproterenol infusion (n = 10)." | 5.07 | A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. ( Bottoni, N; Brignole, M; Gianfranchi, L; Lolli, G; Menozzi, C; Oddone, D, 1992) |
| "0 h after the onset of suspected acute myocardial infarction were randomised either to a control group or to a group receiving atenolol (5-10 mg iv immediately, followed by 100 mg/day orally for 7 days)." | 5.06 | Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. ( , 1986) |
| "Syncope occurred in nine patients (36%) during the baseline tilt and in seven patients (28%) during isoproterenol infusion (total positives 64%)." | 3.68 | Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management. ( Elliott, L; Grubb, BP; Hahn, H; Madu, E; Samoil, D; Temesy-Armos, P; Wolfe, D, 1992) |
| "One hundred thirty-one patients presenting with acute myocardial infarction (AMI) a mean of 3 hours after the onset of symptoms were treated with oral aspirin and intravenous thrombolytic therapy followed by heparin." | 3.68 | Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction. ( Commerford, PJ; Gordon, GD; Green, BK; Horak, AR; Millar, RN, 1992) |
| "The recurrence of neurocardiogenic syncope in highly symptomatic patients treated with atenolol is similar to that of patients treated with placebo." | 2.70 | Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. ( Madrid, AH; Manzano, JG; Moro, C; Ortega, J; Peña, G; Rebollo, JG; Sánchez, A; Segovia, JG, 2001) |
| "We analyzed the incidence and recurrence rate of early and late primary VF in 9,720 patients with a first acute MI, treated with thrombolytics, enrolled in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 trial." | 2.69 | Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database. ( Cavalli, A; Negri, E; Santoro, L; Volpi, A, 1998) |
| "Atenolol was given at a fixed dose of 100 mg per day." | 2.66 | Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. ( Colombo, M; de Franchis, R; Dioguardi, N; Sangiovanni, A; Tommasini, M, 1989) |
| "Stroke affects 15 million people per year worldwide." | 2.50 | Beta-blockers for preventing stroke recurrence. ( Atallah, AN; da Silva, EM; De Lima, LG; Saconato, H, 2014) |
| "A congenital bladder diverticulum (CBD) is caused by inherent muscular weakness instead of obstruction of the bladder outlet." | 1.48 | Bilateral Obstructive Uropathy Caused by Congenital Bladder Diverticulum Presenting as Hypertensive Retinopathy. ( Han, HS; Kim, DY; Kim, S; Lee, OJ; Park, SH; Yun, SJ, 2018) |
| "A vasovagal syncope was considered as the most likely diagnosis." | 1.33 | ["Coffee swallowing syncope"]. ( Schmidt, Ch; Sendi, P, 2005) |
| "The authors report a case of septal panniculitis induced by atenolol in a patient with coronary artery disease." | 1.30 | Septal panniculitis induced by atenolol--a case report. ( Chierchia, SL; Ciboddo, G; Fragasso, G; Pagnotta, P, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 15 (53.57) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Park, SH | 1 |
| Kim, DY | 1 |
| Yun, SJ | 1 |
| Lee, OJ | 1 |
| Han, HS | 1 |
| De Lima, LG | 1 |
| Saconato, H | 1 |
| Atallah, AN | 1 |
| da Silva, EM | 1 |
| Andersen, SS | 1 |
| Hansen, ML | 1 |
| Gislason, GH | 1 |
| Folke, F | 1 |
| Schramm, TK | 1 |
| Fosbøl, E | 1 |
| Sørensen, R | 1 |
| Rasmussen, S | 1 |
| Abildstrøm, SZ | 1 |
| Madsen, M | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| Ganz, PA | 1 |
| Cole, SW | 1 |
| Alegria, JR | 1 |
| Gersh, BJ | 1 |
| Scott, CG | 1 |
| Hodge, DO | 1 |
| Hammill, SC | 1 |
| Shen, WK | 1 |
| Sendi, P | 1 |
| Schmidt, Ch | 1 |
| Ogimoto, A | 1 |
| Shigematsu, Y | 1 |
| Hara, Y | 1 |
| Ohtsuka, T | 1 |
| Miki, T | 1 |
| Higaki, J | 1 |
| Laguna, C | 1 |
| Pérez-Ferriols, A | 1 |
| Alegre, V | 1 |
| Kappelle, LJ | 1 |
| van Latum, JC | 1 |
| van Swieten, JC | 1 |
| Algra, A | 1 |
| Koudstaal, PJ | 1 |
| van Gijn, J | 1 |
| Calkins, H | 1 |
| Seifert, M | 1 |
| Morady, F | 2 |
| Aarøe, J | 1 |
| Hansen, JB | 1 |
| Klein, GJ | 1 |
| Lerman, BB | 1 |
| Tavel, ME | 1 |
| Rashtian, MY | 1 |
| Bhandari, AK | 1 |
| Goodman, S | 1 |
| Hill, C | 1 |
| Bata, I | 1 |
| Fung, A | 1 |
| Higginson, L | 1 |
| Lam, J | 1 |
| Massel, D | 1 |
| McCans, J | 1 |
| Nasmith, J | 1 |
| Stanton, E | 1 |
| Thompson, C | 1 |
| Warnica, W | 1 |
| Langer, A | 1 |
| Fragasso, G | 1 |
| Ciboddo, G | 1 |
| Pagnotta, P | 1 |
| Chierchia, SL | 1 |
| Volpi, A | 1 |
| Cavalli, A | 1 |
| Santoro, L | 1 |
| Negri, E | 1 |
| Fries, R | 1 |
| Heisel, A | 1 |
| Schieffer, H | 1 |
| Madrid, AH | 1 |
| Ortega, J | 1 |
| Rebollo, JG | 1 |
| Manzano, JG | 1 |
| Segovia, JG | 1 |
| Sánchez, A | 1 |
| Peña, G | 1 |
| Moro, C | 1 |
| Wiley, TM | 1 |
| Luu, VD | 1 |
| Grubb, BP | 1 |
| Wolfe, D | 1 |
| Samoil, D | 1 |
| Madu, E | 1 |
| Temesy-Armos, P | 1 |
| Hahn, H | 1 |
| Elliott, L | 1 |
| Green, BK | 1 |
| Gordon, GD | 1 |
| Horak, AR | 1 |
| Millar, RN | 1 |
| Commerford, PJ | 1 |
| Brignole, M | 1 |
| Menozzi, C | 1 |
| Gianfranchi, L | 1 |
| Lolli, G | 1 |
| Bottoni, N | 1 |
| Oddone, D | 1 |
| Scott, JS | 1 |
| Berney, CE | 1 |
| Derksen, FJ | 1 |
| Robinson, NE | 1 |
| Perry, JC | 1 |
| Garson, A | 1 |
| Avezzano, ES | 1 |
| Seefe, LB | 1 |
| Colombo, M | 1 |
| de Franchis, R | 1 |
| Tommasini, M | 1 |
| Sangiovanni, A | 1 |
| Dioguardi, N | 1 |
| Kou, WH | 1 |
| Kadish, AH | 1 |
| Toivonen, LK | 1 |
| Kushner, JA | 1 |
| Schmaltz, S | 1 |
2 reviews available for atenolol and Recrudescence
| Article | Year |
|---|---|
Beta-blockers for preventing stroke recurrence.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Humans; Ischemic Attack, Transient; Randomized Con | 2014 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop | 1990 |
8 trials available for atenolol and Recrudescence
| Article | Year |
|---|---|
Recurrent stroke after transient ischaemic attack or minor ischaemic stroke: does the distinction between small and large vessel disease remain true to type? Dutch TIA Trial Study Group.
Topics: Aged; Aspirin; Atenolol; Cerebral Arteries; Cerebrovascular Disorders; Double-Blind Method; Female; | 1995 |
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Calcium Channel Blockers; Death, Sudden, Cardiac; Dilt | 1996 |
Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atenolol; Drug Administration Routes; Electrocardio | 1998 |
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Double-Blind Method; Female; Humans; | 2001 |
A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope.
Topics: Adult; Atenolol; Bandages; Dihydroergotamine; Domperidone; Female; Humans; Isoproterenol; Male; Midd | 1992 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Prop | 1990 |
Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Atenolol; Clinical Trials a | 1989 |
Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
Topics: Administration, Oral; Age Factors; Aged; Atenolol; Cardiotonic Agents; Clinical Trials as Topic; Dru | 1986 |
19 other studies available for atenolol and Recrudescence
| Article | Year |
|---|---|
Bilateral Obstructive Uropathy Caused by Congenital Bladder Diverticulum Presenting as Hypertensive Retinopathy.
Topics: Adolescent; Antihypertensive Agents; Atenolol; Creatinine; Diverticulum; Humans; Hypertensive Retino | 2018 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male | 2009 |
Expanding our therapeutic options: Beta blockers for breast cancer?
Topics: Adrenergic beta-Antagonists; Atenolol; Breast Neoplasms; Diabetes Complications; Disease-Free Surviv | 2011 |
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; M | 2003 |
["Coffee swallowing syncope"].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Ateno | 2005 |
Black pearl in the LIFE study: angiotensin-II receptor blockade on atrial fibrillation for future personalized medicine.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atenolol; Atrial Fibrillation; Bla | 2005 |
Superficial migratory thrombophlebitis in a hypertensive patient: response to antihypertensive therapy.
Topics: Adult; Antihypertensive Agents; Atenolol; Diagnosis, Differential; Female; Humans; Hypertension; Rec | 2008 |
Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.
Topics: Adolescent; Adult; Age of Onset; Atenolol; Bradycardia; Disopyramide; Drug Combinations; Exercise; E | 1995 |
[Tilt-induced vasovagal syncope].
Topics: Adult; Atenolol; Female; Humans; Hypotension, Orthostatic; Posture; Recurrence; Syncope; Vagus Nerve | 1994 |
Syncope: common clinical problem of diagnosis and management.
Topics: Atenolol; Bradycardia; Female; Humans; Hypotension, Orthostatic; Middle Aged; Recurrence; Syncope | 1994 |
Worsening of neurocardiogenic syncope by beta-blockers.
Topics: Adult; Atenolol; Humans; Male; Recurrence; Syncope | 1993 |
Septal panniculitis induced by atenolol--a case report.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Unstable; Atenolol; Female; Humans; Panniculitis; Recurre | 1998 |
Influence of beta-blockers on the frequency of arrhythmia recurrences in patients with implantable cardioverter-defibrillator: an intraindividual comparison.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Atenolol; Defibrillators, Impla | 1998 |
Recurrent syncope in a 31-year-old army staff sergeant.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Case Management; Humans; Ma | 2002 |
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.
Topics: Aged; Aged, 80 and over; Atenolol; Beds; Blood Pressure; Disopyramide; Drug Therapy, Combination; El | 1992 |
Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction.
Topics: Administration, Oral; Adult; Aspirin; Atenolol; Combined Modality Therapy; Female; Humans; Infusions | 1992 |
Beta-adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease.
Topics: Aerosols; Animals; Atenolol; Butoxamine; Histamine; Horse Diseases; Horses; Isoproterenol; Lung Dise | 1991 |
The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity.
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Autonomic Nervous System; Child; Epinephrine; Fem | 1991 |
Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia.
Topics: Atenolol; Cardiac Pacing, Artificial; Electrophysiology; Epinephrine; Female; Humans; Male; Middle A | 1989 |